Zobrazeno 1 - 10
of 79
pro vyhledávání: '"B. Mary E. von Blomberg"'
Autor:
Sascha Gross, Roy L. van Wanrooij, Petula Nijeboer, Kyra A. Gelderman, Saskia A. G. M. Cillessen, Gerrit A. Meijer, Chris J. J. Mulder, Gerd Bouma, B. Mary E. von Blomberg, Hetty J. Bontkes
Publikováno v:
Mediators of Inflammation, Vol 2013 (2013)
A small fraction of coeliac disease (CD) patients have persistent villous atrophy despite strict adherence to a gluten-free diet. Some of these refractory CD (RCD) patients develop a clonal expansion of lymphocytes with an aberrant phenotype, referre
Externí odkaz:
https://doaj.org/article/54bde9a07788469682507a9407ba1231
Autor:
Rik J. Scheper, Dessy Rachmawati, B. Mary E. von Blomberg, Cornelis J. Kleverlaan, Ingrid M.W. van Hoogstraten
Publikováno v:
Journal of Prosthetic Dentistry, 117(5), 677-684. Mosby Inc.
Rachmawati, D, von Blomberg, B M E, Kleverlaan, C J, Scheper, R J & van Hoogstraten, I M W 2017, ' Immunostimulatory capacity of dental casting alloys on endotoxin responsiveness ', Journal of Prosthetic Dentistry, vol. 117, no. 5, pp. 677-684 . https://doi.org/10.1016/j.prosdent.2016.08.013
Rachmawati, D, von Blomberg, B M E, Kleverlaan, C J, Scheper, R J & van Hoogstraten, I M W 2017, ' Immunostimulatory capacity of dental casting alloys on endotoxin responsiveness ', Journal of Prosthetic Dentistry, vol. 117, no. 5, pp. 677-684 . https://doi.org/10.1016/j.prosdent.2016.08.013
Statement of problem: Oral metal exposure has been associated with systemic and local adverse reactions, probably due to elemental release from the alloys. Although supraphysiological concentrations of salts from dentally applied metals can activate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab2b62b5cf02b0b1dd9f05bf33a82743
http://www.scopus.com/inward/record.url?scp=85005949178&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85005949178&partnerID=8YFLogxK
Publikováno v:
Kanerva’s Occupational Dermatology ISBN: 9783319402215
Rustemeyer, T, Van Hoogstraten, I M W, Von Blomberg, B M E & Scheper, R J 2019, Mechanisms of allergic contact dermatitis . in Kanerva's Occupational Dermatology . Springer International Publishing AG, pp. 151-190 . https://doi.org/10.1007/978-3-319-68617-2_14
Kanerva's Occupational Dermatology, 151-190
STARTPAGE=151;ENDPAGE=190;TITLE=Kanerva's Occupational Dermatology
Rustemeyer, T, Van Hoogstraten, I M W, Von Blomberg, B M E & Scheper, R J 2019, Mechanisms of allergic contact dermatitis . in Kanerva's Occupational Dermatology . Springer International Publishing AG, pp. 151-190 . https://doi.org/10.1007/978-3-319-68617-2_14
Kanerva's Occupational Dermatology, 151-190
STARTPAGE=151;ENDPAGE=190;TITLE=Kanerva's Occupational Dermatology
Allergenicity depends on several factors determined by the very physicochemical nature of the molecules themselves, i.e., their capacity to penetrate the horny layer, lipophilicity, and chemical reactivity. The sensitizing property of the majority of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd19a5f57e7d713b1b7763fb8d1a9f57
https://doi.org/10.1007/978-3-319-40221-5_14-2
https://doi.org/10.1007/978-3-319-40221-5_14-2
Autor:
Sascha Gross, Gerd Bouma, B. Mary E. von Blomberg, Sjoerd F. Bakker, Ingrid M.W. van Hoogstraten, Hetty J. Bontkes, Adriaan A. van Bodegraven, Chris J. J. Mulder, Kyra A. Gelderman
Publikováno v:
Journal of Gastrointestinal and Liver Diseases, 23(2), 127-133. Romanian Society of Gastroenterology
Scopus-Elsevier
Gross, S, Bakker, S F, van Bodegraven, A A, van Hoogstraten, I M W, Gelderman, K A, Bouma, G, Mulder, C J, von Blomberg, B M E & Bontkes, H J 2014, ' Increased IgA Glycoprotein-2 Specific Antibody Titres in Refractory Celiac Disease ', Journal of Gastrointestinal and Liver Diseases, vol. 23, no. 2, pp. 127-133 . https://doi.org/10.15403/jgld.2014.1121.232.sg1
Scopus-Elsevier
Gross, S, Bakker, S F, van Bodegraven, A A, van Hoogstraten, I M W, Gelderman, K A, Bouma, G, Mulder, C J, von Blomberg, B M E & Bontkes, H J 2014, ' Increased IgA Glycoprotein-2 Specific Antibody Titres in Refractory Celiac Disease ', Journal of Gastrointestinal and Liver Diseases, vol. 23, no. 2, pp. 127-133 . https://doi.org/10.15403/jgld.2014.1121.232.sg1
Background & Aims: In most cases celiac disease (CD) is successfully treated with a gluten-free diet (GFD). However, some patients become refractory to the GFD. Refractory CD (RCD) patients have an increased risk for developing enteropathy associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3ca6f9db5b12eca00d76e7e6c75aa6
https://doi.org/10.15403/jgld.2014.1121.232.sg1
https://doi.org/10.15403/jgld.2014.1121.232.sg1
Autor:
Alfons J.M. van den Eertwegh, Natalie Sacks, Rik J. Scheper, Israel Lowy, Jean Marie Cuillerot, Petra E.T. Scholten, Helen Gall, Martine Reijm, Karin Jooss, Winald R. Gerritsen, Sinéad M. Lougheed, B. Mary E. von Blomberg, Anita G.M. Stam, Tanja D. de Gruijl, Saskia J. A. M. Santegoets, Kristen Hege
Publikováno v:
Cancer Immunology Immunotherapy, 62, 245-56
Cancer Immunology and Immunotherapy, 62(2), 245-256. Springer Science and Business Media Deutschland GmbH
Santegoets, S J A M, Stam, A G M, Lougheed, S M, Gall, H, Scholten, P E T, Reijm, M, Jooss, K, Sacks, N, Hege, K, Lowy, I, Cuillerot, J M, von Blomberg, B M E, Scheper, R J, van den Eertwegh, A J M, Gerritsen, W R & de Gruijl, T D 2013, ' T cell profiling reveals high CD4(+)CTLA-4(+) T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment ', Cancer Immunology and Immunotherapy, vol. 62, no. 2, pp. 245-256 . https://doi.org/10.1007/s00262-012-1330-5
Cancer Immunology Immunotherapy, 62, 2, pp. 245-56
Cancer Immunology and Immunotherapy, 62(2), 245-256. Springer Science and Business Media Deutschland GmbH
Santegoets, S J A M, Stam, A G M, Lougheed, S M, Gall, H, Scholten, P E T, Reijm, M, Jooss, K, Sacks, N, Hege, K, Lowy, I, Cuillerot, J M, von Blomberg, B M E, Scheper, R J, van den Eertwegh, A J M, Gerritsen, W R & de Gruijl, T D 2013, ' T cell profiling reveals high CD4(+)CTLA-4(+) T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment ', Cancer Immunology and Immunotherapy, vol. 62, no. 2, pp. 245-256 . https://doi.org/10.1007/s00262-012-1330-5
Cancer Immunology Immunotherapy, 62, 2, pp. 245-56
Item does not contain fulltext Immune checkpoint blockade enhances antitumor responses, but can also lead to severe immune-related adverse events (IRAE). To avoid unnecessary exposure to these potentially hazardous agents, it is important to identify
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64421fe4dc84732c4795392fa926710
https://doi.org/10.1007/s00262-012-1330-5
https://doi.org/10.1007/s00262-012-1330-5
Autor:
Alfons J.M. van den Eertwegh, Thomas Harding, Natalie Sacks, Saskia J. A. M. Santegoets, R. Jeroen A. van Moorselaar, Kristen Hege, Rik J. Scheper, Israel Lowy, Winald R. Gerritsen, Tim M. van der Sluis, Herbert M. Pinedo, Karin Jooss, Anita G.M. Stam, Jurjen Versluis, B. Mary E. von Blomberg, H Pieter van den Berg, Tanja D. de Gruijl, H.E. Gall
Publikováno v:
van den Eertwegh, A J M, Versluis, J P, van den Berg, H P, Santegoets, S J A M, van Moorselaar, R J A, van der Sluis, T M, Gall, H E, Harding, T C, Jooss, K, Lowy, I, Pinedo, H M, Scheper, R J, Stam, A G M, von Blomberg, B M E, de Gruijl, T D, Hege, K, Sacks, N & Gerritsen, W R 2012, ' Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial ', Lancet Oncology, vol. 13, no. 5, pp. 509-517 . https://doi.org/10.1016/S1470-2045(12)70007-4
Lancet Oncology, 13, 5, pp. 509-17
Lancet Oncology, 13, 509-17
Lancet Oncology, 13(5), 509-517. Lancet Publishing Group
Lancet Oncology, 13, 5, pp. 509-17
Lancet Oncology, 13, 509-17
Lancet Oncology, 13(5), 509-517. Lancet Publishing Group
Item does not contain fulltext BACKGROUND: The granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells vaccine (GVAX) has antitumour activity against prostate cancer; preclinical studies have shown potent synergy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::118cbcde44b17c9dde184e406c0ae9cc
https://doi.org/10.1016/s1470-2045(12)70007-4
https://doi.org/10.1016/s1470-2045(12)70007-4
Autor:
F. Koning, B. Mary E. von Blomberg, Anton W. Langerak, Jeroen van Bergen, Gerd Bouma, Chris J. J. Mulder, Jennifer M.L. Tjon, Marco W.J. Schreurs, Daniëlle A.M. Heideman, Roy L. van Wanrooij, Greetje J. Tack
Publikováno v:
Tack, G J, van Wanrooij, R L J, Langerak, A W, Tjon, J M L, von Blomberg, B M E, Heideman, D A M, van Bergen, J, Koning, F, Bouma, G, Mulder, C J J & Schreurs, M W J 2012, ' Origin and immunophenotype of aberrant IEL in RCDII patients ', Molecular Immunology, vol. 50, no. 4, pp. 262-270 . https://doi.org/10.1016/j.molimm.2012.01.014
Molecular Immunology, 50(4), 262-270. Elsevier Limited
Molecular Immunology, 50(4), 262-270
Molecular Immunology, 50(4), 262-270. Elsevier Ltd.
Molecular Immunology, 50(4), 262-270. Elsevier Limited
Molecular Immunology, 50(4), 262-270
Molecular Immunology, 50(4), 262-270. Elsevier Ltd.
Objectives: Aberrant intra-epithelial lymphocytes (IELs) are the hallmark of refractory coeliac disease type II RCDII and considered a premalignant cell population from which aggressive enteropathy-associated T cell lymphoma (EATL) can evolve. The ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae8983c516e17cc5279226eb9dddaa43
https://doi.org/10.1016/j.molimm.2012.01.014
https://doi.org/10.1016/j.molimm.2012.01.014
Publikováno v:
European Journal of Pediatrics, 171(7), 1011-1021. Springer Verlag
Kneepkens, C M F & von Blomberg, B M E 2012, ' Clinical practice Coeliac disease ', European Journal of Pediatrics, vol. 171, no. 7, pp. 1011-1021 . https://doi.org/10.1007/s00431-012-1714-8
Kneepkens, C M F & von Blomberg, B M E 2012, ' Clinical practice Coeliac disease ', European Journal of Pediatrics, vol. 171, no. 7, pp. 1011-1021 . https://doi.org/10.1007/s00431-012-1714-8
Coeliac disease (CD) is an immune-mediated systemic condition elicited by gluten and related prolamines in genetically predisposed individuals and characterised by gluten-induced symptoms and signs, specific antibodies, a specific human leukocyte ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d90ce4127274b727d2a81ba211f32a
https://doi.org/10.1007/s00431-012-1714-8
https://doi.org/10.1007/s00431-012-1714-8
Autor:
Mirjam, de Vries, Irene, van der Horst-Bruinsma, Ingrid, van Hoogstraten, Adriaan, van Bodegraven, B Mary E, von Blomberg, Mary, von Blomberg, Hana, Ratnawati, Ben, Dijkmans
Publikováno v:
de Vries, M K, van der Horst-Bruinsma, I E, van Hoogstraten, I M W, van Bodegraven, A A, von Blomberg, B M E, Ratnawati, H & Dijkmans, B A C 2010, ' pANCA, ASCA, and OmpC Antibodies in Patients with Ankylosing Spondylitis without Inflammatory Bowel Disease ', Journal of Rheumatology, vol. 37, no. 11, pp. 2340-2344 . https://doi.org/10.3899/jrheum.100269
Journal of Rheumatology, 37(11), 2340-2344. Journal of Rheumatology
Journal of Rheumatology, 37(11), 2340-2344. Journal of Rheumatology
Objective.Patients with ankylosing spondylitis (AS) can suffer concurrently from inflammatory bowel disease (IBD), as ulcerative colitis (UC) or Crohn’s disease (CD). Serological markers have been described to diagnose IBD. We investigated IBD sero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25df9617a3204c1cf46b200117d21c8e
https://doi.org/10.3899/jrheum.100269
https://doi.org/10.3899/jrheum.100269
Autor:
Jeroen Wouters, J. Bart A. Crusius, Marco W.J. Schreurs, Laura R. de Baaij, Chantal J.M. Broers, Michel E. Weijerman, Reinoud J. B. J. Gemke, A. Marceline van Furth, B. Mary E. von Blomberg
Publikováno v:
Wouters, J, Weijerman, M E, van Furth, A M, Schreurs, M W J, Crusius, J B A, von Blomberg-van der Flier, B M E, de Baaij, L R, Broers, C J M & Gemke, R J B J 2009, ' Prospective Human Leukocyte Antigen, Endomysium Immunoglobulin A Antibodies, and Transglutaminase Antibodies Testing for Celiac Disease in Children with Down Syndrome ', Journal of Pediatrics, vol. 154, no. 2, pp. 239-242 . https://doi.org/10.1016/j.jpeds.2008.08.007
Journal of Pediatrics, 154(2), 239-242. Mosby Inc.
Journal of Pediatrics, 154(2), 239-242. Mosby Inc.
Objective To assess the effect of a prospective screening strategy for the early diagnosis of celiac disease (CD) in children with Down syndrome (DS). Study design Blood samples were taken from 155 children with DS. Buccal swabs were also taken from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1943f9c3878d490fd8ce50e9c210d2
https://doi.org/10.1016/j.jpeds.2008.08.007
https://doi.org/10.1016/j.jpeds.2008.08.007